Triple Combination Immunotherapy With GVAX, Anti-Pd-1 Monoclonal Antibody, and Agonist Anti-Ox40 Monoclonal Antibody Is Highly Effective Against Murine Intracranial Glioma
OncoImmunology - United States
doi 10.1080/2162402x.2019.1577108
Full Text
Open PDFAbstract
Available in full text
Date
February 27, 2019
Authors
Publisher
Informa UK Limited